Patient Guide: A Study to Evaluate MEDI5752 and Axitinib in Subjects With Advanced Renal Cell Carcinoma

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 20 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT04522323
Status: ACTIVE_NOT_RECRUITING
Condition: Advanced Renal Cell Carcinoma
Phase: PHASE1

Where You Can Participate

This study is available at 20 locations across the country.

Top locations include:
  • • Washington, District of Columbia
  • • Fort Myers, Florida
  • • Saint Louis, Missouri
  • • And 17 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study to Evaluate MEDI5752 and Axitinib in Subjects With Advanced Renal Cell Carcinoma - Join Clinical Trial NCTNCT04522323

How to Join This Clinical Trial - NCTNCT04522323

Learn how to participate in this PHASE1 trial studying an investigational therapy for Advanced Renal Cell Carcinoma. Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Advanced Renal Cell Carcinoma. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Advanced Renal Cell Carcinoma
Treatment Being Tested
Investigational treatment
Study Phase
PHASE1 - Early safety study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT04522323 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 20 locations. Find a study site near you:

Clinical Research Site

Washington, District of Columbia 20007 - United States

Status: Contact for availability

Clinical Research Site

Fort Myers, Florida 33908 - United States

Status: Contact for availability

Clinical Research Site

Saint Louis, Missouri 63156 - United States

Status: Contact for availability

Clinical Research Site

New York, New York 10065 - United States

Status: Contact for availability

Clinical Research Site

Cleveland, Ohio 44195 - United States

Status: Contact for availability

Clinical Research Site

Hershey, Pennsylvania 17033 - United States

Status: Contact for availability

Clinical Research Site

Nashville, Tennessee 37232 - United States

Status: Contact for availability

Clinical Research Site

Frankston, 3199 - Australia

Status: Contact for availability

Clinical Research Site

Waratah, 2298 - Australia

Status: Contact for availability

Clinical Research Site

Villejuif Cedex, 94805 - France

Status: Contact for availability

And 10 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE1 clinical trial for Advanced Renal Cell Carcinoma:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships